When it comes to managing psoriatic disease, comorbidities have a substantial impact on the individual therapeutic decision making. It’s all about the complete clinical picture, and all of the problems the patients face.
In Section 1 of this accredited e-learning, Prof. Wolf-Henning Boehncke approaches the relationship between psoriasis and psoriatic arthritis, in his approach as a dermatologist and GRAPPA board member.
Section 2 and 3 will update you on the epidemiology and pathophysiology of the comorbidities associated with psoriatic disease.
The more practical aspects of consequences of managing the comorbidities and the truly comprehensive concept to manage all the health issues of the psoriatic patient, will be addressed in more detail in Section 4 and 5.
In the final Section (6), he will briefly talk about treating mild psoriasis. Every section is wrapped-up with some questions and answers.
Head, Division of Dermatology and Venereology, Geneva University Hospitals
Full Professor, Dpt. of Pathology and Immunology, Faculty of Medicine, University of Geneva
Wolf-Henning Boehncke earned his M.D. as a fellow of the German Scholarship Foundation in Kiel and Glasgow, and received his postdoctoral training at the National Institutes of Health in Bethesda/USA. Following assignments at the University Hospitals in Kiel and Ulm he became Full Professor and Head of the Section of Allergy/Immunology at the Goethe-University in Frankfurt/Main. Since 2012, he is the Chairman of the Dermatology Unit at Geneva University.
Prof. Boehncke is a board member of numerous psoriasis initiatives, including the German psoriasis registry (PsoBest©) and the network to improve psoriasis management (PsoNet©) as well as the German psoriasis patients organization. He is the current president of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and an active member of the International Psoriasis Council (IPC).
His research focuses on the pathogenesis of inflammation on which he published landmark papers in the New England Journal of Medicine, Nature Medicine, and Nature, several of these were honoured by distinguished prizes including the Galenus-von-Pergamon prize.
Endocrinology and metabolic diseases
Geaccrediteerd voor artsen (N° 24010541 - 1 punt)
Cardiology
Geaccrediteerd voor artsen (N° 23002062 - 0.5 punt)
Accreditatie is verlengd
Oncology
Geaccrediteerd voor artsen (N° 24004752 - 1 punt)
Geaccrediteerd voor artsen (N° 24003263 - 1 punt)
Cardiology
Geaccrediteerd voor artsen (N° 24000055 - 1 punt)
Geaccrediteerd voor artsen - 23002062 - 0.5CP
Geaccrediteerd voor artsen - 24004752 - 1CP
Geaccrediteerde lectuur voor artsen (24003263 - 1 CP)
Geaccrediteerd voor artsen - 24000055 - 1CP
